Bajaj FInserv Multi Cap Fund - Regular - Growth
Category: Equity: Multi Cap
Launch Date: 27-02-2025
AUM:
₹ 1,641.36 Cr
Expense Ratio
2.55%
Benchmark
Nifty500 Multicap 50:25:25 TRI
ISIN
INF0QA701AS3
Minimum Investment
500.0
Minimum Topup
100.0
Minimum SIP Amount
500
Fund Manager
Mr. Nimesh Chandan, Mr. Sorbh Gupta, Mr. Siddharth Chaudhary
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Bajaj FInserv Multi Cap Fund - Regular - Growth | 4.45 | - | - |
| NIFTY500 MULTICAP 50:25:25 TRI | -1.75 | 12.19 | 10.83 |
Asset Allocation
Equity
Debt
Others
Overview
NAV
11.889
Last change
0.16 (1.329%)
Fund Size (AUM)
₹ 1,641.36 Cr
Performance
10.77% (Inception)
Investment Objective
The objective of the Scheme is to generate long term capital appreciation by investing in equity and equity related securities of large cap, mid cap and small cap companies. However, there is no assurance that the investment objective of the Scheme will be achieved.
Fund Manager
Mr. Nimesh Chandan, Mr. Sorbh Gupta, Mr. Siddharth Chaudhary
Riskometer
Very High
Overview
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| HDFC BANK LIMITED EQ NEW FV RE. 1/- | 9.73 |
| BHARTI AIRTEL LIMITED EQ NEW FV RS 5/- | 4.54 |
| RELIANCE INDUSTRIES LIMITED EQ | 4.15 |
| SCHAEFFLER INDIA LIMITED EQ NEW FV RS. 2/- | 3.09 |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD EQ | 2.65 |
| THE FEDERAL BANK LIMITED EQ NEW FV RS.2/- | 2.53 |
| DLF LIMITED EQ NEW FV RS.2/- | 2.46 |
| Zydus Wellness Ltd | 2.42 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 2.4 |
| STERLITE TECHNOLOGIES LIMITED EQ NEW F.V. RS.2/- | 2.32 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Financial Services | 25.94 |
| Automobile and Auto Components | 9.26 |
| Metals & Mining | 8.02 |
| Telecommunication | 7.56 |
| Healthcare | 6.36 |
| Consumer Services | 5.97 |
| Construction | 4.59 |
| Textiles | 4.42 |
| Oil, Gas & Consumable Fuels | 4.15 |
| Capital Goods | 3.88 |
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| Bajaj Finserv Multi Cap Fund Reg Gr | 0.0 |